A Preliminary Trial of Safety and Feasibility of Ketamine-assisted Psychotherapy in Adolescents With Posttraumatic Stress-disorder.

This document provides information about two separate clinical trials conducted by the University of Wisconsin, Madison. The first trial, NCT06378528, focuses on investigating the feasibility, tolerability, and efficacy of repeated ketamine-assisted psychotherapy sessions in adolescents with severe posttraumatic stress disorder (PTSD). The trial aims to enroll adolescents with a current diagnosis of PTSD to complete three intravenous ketamine administrations immediately prior to a psychotherapy session over the span of six weeks. The second trial explores the effects of ketamine and the use of a SmartSleep EEG recording headband on sleep patterns. This trial is not yet recruiting participants and is estimated to be completed by August 2025. The eligibility criteria for participants are outlined, and the responsible party for both trials is the University of Wisconsin, Madison. [Extracted from the article]

Copyright of Clinical Trials Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)